TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WYNSUNEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

WYNSUNEL

ST13

US500000098461007

Class

5

Filing

98461007

Registration

7999120

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

10/28/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

03/21/2024

Registration date

10/28/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/28/2025

Last transaction

10/28/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

Stevenage, GB

Examiner

YOUNG, CARRIE SKYE

Law office

M80

Current location

INTENT TO USE SECTION

Holders and representatives

Holders

GLAXO GROUP LIMITED

Representatives

Elizabeth K. Rucki GSK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases

Publications

History of USPTO decisions and trademark events.

18 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/28/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/08/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/08/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/08/2025

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

09/26/2025

GRML

CORRESPONDENCE E-MAILED

09/17/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/17/2025

INOA

AMENDMENT AFTER NOA NOT ENTERED

06/11/2025

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

06/11/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/17/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/05/2024

PUBO

PUBLISHED FOR OPPOSITION

11/05/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/16/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/29/2024

DOCK

ASSIGNED TO EXAMINER

09/29/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/02/2024

NWAP

NEW APPLICATION ENTERED

03/21/2024

Continuous trademark protection

Get notified about every new filing that threatens WYNSUNEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.